Kendle International, Inc. (KNDL)
$15.41
-0.38 (-2.41%)
| CAPS Rating |
|
|---|---|
| Open | $15.30 |
| Previous Close | $15.79 |
| Daily Range | $15.30 - $15.73 |
| 52-Week Range | $8.28 - $26.36 |
| Market Cap | $229.33M |
| P/E Ratio | 10.77 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 75,855 |
| Average Daily Volume | 194,000 |
KNDL
VS S&P 500 (SPY)
How do you think KNDL will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
KNDL Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
KNDL News and Commentary
- UPDATE 1-Kendle Q3 profit beats Street – Reuters
- 5-Star Stocks on the Upswing – The Motley Fool
- Accountability for the 5 Stocks I bought 10 days ago with real money. – Blog at The Motley Fool
- 5 stocks I bought today (real money) – Blog at The Motley Fool
- Nothing to CRO About – The Motley Fool
- Drug CROs: Good Medicine for Investors – The Motley Fool
- 5 Stocks Ready for Liftoff – The Motley Fool
- 5-Star Stocks on the Upswing – The Motley Fool
- Wednesday's Top 5 Growth Winners – The Motley Fool
- Today's Strong Buys – The Motley Fool
- 7 Highly Rated Stocks on Sale – The Motley Fool
Related News and Articles
- 4-Star Stocks Poised to Pop: Sequenom – The Motley Fool
- How Do You Say 'Drug Development' in Mandarin? – The Motley Fool
- 3 Stocks Hitting High Notes – The Motley Fool
- Pharma Researchers Need a Cure – The Motley Fool
- The Waters Aren't Flowing. Yet. – The Motley Fool
- Ugly, but Still Built for Growth – The Motley Fool
- Taking the Drug Industry's Temperature – The Motley Fool
RSS Headlines
Fool UK
